Bhxky4pz3e2ooonkc34tg40j
Bhxky4pz3e2ooonkc34tg40j
Bhxky4pz3e2ooonkc34tg40j
Test Report
Interpretation
-------------------------------------------------------------------
| KIDNEY TRANSPLANT | POST TRANSPLANT | THERAPEUTIC RANGE in ug/L |
|-------------------|-------------------|----------------------------|
| PEDIATRIC | 0-3 months | 10-12 |
| | 3-6 months | 8-10 |
| | 6-12 months | 6-8 |
| | >12 months | 4-7 |
|-------------------|-------------------|----------------------------|
| ADULT | 0-6 months | 8-10 |
| | 6-12 months | 6-8 |
| | >12 months | 4-6 |
| | >5 Years | 3-5 |
|-------------------|-------------------|----------------------------|
| | Toxic range | >20 |
--------------------------------------------------------------------
-------------------------------------------------------------------
| LIVER TRANSPLANT | POST TRANSPLANT | THERAPEUTIC RANGE in ug/L |
|-------------------|-------------------|----------------------------|
| PEDIATRIC | 0-3 months | 10-12 |
| | 3-6 months | 8-10 |
| | >6 months | 6-8 |
|-------------------|-------------------|----------------------------|
| ADULT | 0-3 months | 10-12 |
| | 3-6 months | 8-10 |
| | >6 months | 6-8 |
|-------------------|-------------------|----------------------------|
| | Toxic range | >20 |
--------------------------------------------------------------------
Note: 1. Therapeutic range is based on whole blood specimen drawn 12 hrs post dose or prior
to next dose (trough)
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*389881693*
Page 1 of 3
.
Test Report
Comments
LC-MS/MS is considered the most sensitive, specific and precise technology for monitoring
immunosuppressants . Therapeutic drug monitoring ( TDM) is commonly used to help maintain drug levels
within the concentration range in which the drug exerts its clinical effect with minimal adverse reactions.
Tacrolimus is a potent immunosuppressant approved for prophylaxis of organ rejection in patients receiving
allogeneic liver transplants. It has also been used effectively in other solid organ transplant patients like kidney
transplant for prevention of graft versus host disease as well as in pancreatic islet transplantation. It exerts
immunosuppressive effect following the formation of a complex with immunophilins. It’s absorption from
small intestine is highly variable ranging from 4-93% and changes with time following transplant surgery.
Even the elimination half life of Tacrolimus is variable being 12 hours in liver transplant patients and 19 hours
in renal transplant patients.
Indications for testing
· Immunosuppressant dose optimization
· Failure to respond to immuosuppressants
· Signs or Symptoms consistent with inadequate or excessive immunosuppression
· Changes to concomitant medications or other variables that affect pharmacokinetics
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*389881693*
Page 2 of 3
.
Test Report
IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum
at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.ŸThe report does
not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*389881693*
Page 3 of 3